{"context":{"query":">>pharmgkb_gene>>pharmgkb","source_dataset":"pharmgkb_gene","target_dataset":"pharmgkb"},"stats":{"queried":1,"total":17,"mapped":1},"pagination":{"has_next":false},"schema":"id|name|type|clinical_annotation_count|variant_annotation_count|pathway_count","mappings":[{"input":"PA25408","source":"PA25408|B-Raf proto-oncogene, serine/threonine kinase","targets":["PA10040|cetuximab|Drug|15|87|1","PA165946873|vemurafenib|Drug|0|2|1","PA166114911|dabrafenib|Drug|0|3|1","PA166115364|trametinib|Drug|0|0|0","PA166124615|pembrolizumab|Drug|0|12|0","PA166129522|nivolumab|Drug|0|11|0","PA166129523|atezolizumab|Drug|0|7|0","PA166129529|selumetinib|Drug|0|12|0","PA166160044|cobimetinib|Drug|0|0|0","PA166179867|binimetinib|Drug|0|0|1","PA166179872|encorafenib|Drug|0|0|0","PA166182862|FOLFOX|Drug|2|38|0","PA166182863|FOLFIRI|Drug|4|66|0","PA166182864|XELOX|Drug|1|22|0","PA166277902|nivolumab / relatlimab|Drug|0|0|0","PA166345561|tovorafenib|Drug|0|0|0","PA7000|sorafenib|Drug|40|80|3"]}]}